Pinteon Therapeutics
Suzanne Hendrix, Ph.D., is CEO of Pentara Corporation in Salt Lake City, Utah, a statistical consulting firm. Suzanne’s main research focus and clinical interests are optimizing measurement and analysis in clinical trials of Alzheimer’s and other degenerative diseases. Suzanne has over 150 publications as well as many presentations, posters and webinars. Suzanne received her Ph.D. from Boston University.
This person is not in the org chart
This person is not in any offices
Pinteon Therapeutics
1 followers
Pinteon Therapeutics is advancing clinical studies of a novel antibody that aims to interrupt the spread of toxic tau and protect and preserve brain function in patients with neurodegenerative disease.